Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: A randomized controlled study

AIM: To observe the efficiency and safety of thymosin-α1 treatment in patients with hepatitis B e antigen (HBeAg) and HBV DNA positive chronic hepatitis. METHODS: Sixty-two patients were randomly divided into groups A and B. The patients in group A received subcutaneous injection of 1.6 mg thymosin-...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: You, Jing, Zhuang, Lin, Cheng, Hong-Ying, Yan, Shou-Ming, Yu, Lan, Huang, Jun-Hua, Tang, Bao-Zhang, Huang, Meng-Ling, Ma, Yong-Liang, Chongsuvivatwong, Virasakdi, Sriplung, Hutcha, Geater, Alan, Qiao, Yan-Wei, Wu, Rong-Xue
Natura: Artigo
Lingua:Inglês
Pubblicazione: Baishideng Publishing Group Co., Limited 2006
Soggetti:
Rapid Communication
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4125683/
https://ncbi.nlm.nih.gov/pubmed/17075991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v12.i41.6715
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi